These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 19181017

  • 21. Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents.
    Muehlbauer PA, Schuler MJ.
    Mutat Res; 2005 Aug 01; 585(1-2):156-69. PubMed ID: 15996509
    [Abstract] [Full Text] [Related]

  • 22. Epidemiology of aplastic anemia: a prospective multicenter study.
    Montané E, Ibáñez L, Vidal X, Ballarín E, Puig R, García N, Laporte JR, Catalan Group for Study of Agranulocytosis and Aplastic Anemia.
    Haematologica; 2008 Apr 01; 93(4):518-23. PubMed ID: 18322256
    [Abstract] [Full Text] [Related]

  • 23. Aplastic anemia and monosomy 7-associated dysmegakaryocytopoiesis.
    Dolan MM, Singleton TP, Neglia J, Cioc A.
    Am J Clin Pathol; 2006 Dec 01; 126(6):925-30. PubMed ID: 17074689
    [Abstract] [Full Text] [Related]

  • 24. [Analysis of DNA aneuploidy as a tumor marker].
    Takamoto S, Kato H.
    Rinsho Ketsueki; 1990 Jun 01; 31(6):729-35. PubMed ID: 2214164
    [Abstract] [Full Text] [Related]

  • 25. [Clinico-laboratory variants of the course and results of therapy of hepatitis-associated aplastic anemias in children].
    Novichkova GA, Maschan MA, Kravchenko EG, Baĭdil'dina DD, Bogacheva NIu, Goronkova OV, Zharikova LI, Litvinov DV, Solopova GG, Suntsova EV, Shneĭder MM, Khachatrian LA, Skorobogatova EV, Shipitsyna IP, Trakhtman PE, Balashov DN, Maschan AA.
    Ter Arkh; 2007 Jun 01; 79(7):57-61. PubMed ID: 17802792
    [Abstract] [Full Text] [Related]

  • 26. Full karyotyping, rapid aneuploidy diagnosis or both when invasive prenatal testing is performed for diagnosis of thalassaemia?
    Tse KY, Leung WC, Leung KY, Lee CP, Ng LK, Lau ET, Chan V, Tang MH.
    Mol Hum Reprod; 2006 Jan 01; 12(1):55-9. PubMed ID: 16421217
    [Abstract] [Full Text] [Related]

  • 27. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
    Pinto AE, Silva G, Banito A, Leite V, Soares J.
    Oncol Rep; 2008 Oct 01; 20(4):913-9. PubMed ID: 18813835
    [Abstract] [Full Text] [Related]

  • 28. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
    Put N, Konings P, Rack K, Jamar M, Van Roy N, Libouton JM, Vannuffel P, Sartenaer D, Ameye G, Speleman F, Herens C, Poirel HA, Moreau Y, Hagemeijer A, Vandenberghe P, Michaux L, Belgian Cytogenetic Group for Hemato-Oncology (BCGHO).
    Genes Chromosomes Cancer; 2009 Oct 01; 48(10):843-53. PubMed ID: 19582829
    [Abstract] [Full Text] [Related]

  • 29. Ticlopidine-induced aplastic anemia: development of chromosomal abnormalities and response to immunosuppressive therapy.
    Pullarkat VA, Rho H, Murata-Collins JL, Liebman HA.
    Am J Hematol; 2000 Mar 01; 63(3):141-4. PubMed ID: 10679804
    [Abstract] [Full Text] [Related]

  • 30. Spontaneous remission of aplastic anemia: a retrospective analysis.
    Lee JH, Lee JH, Shin YR, Lee JS, Kim WK, Chi HS, Park CJ, Lee KH.
    Haematologica; 2001 Sep 01; 86(9):928-33. PubMed ID: 11532620
    [Abstract] [Full Text] [Related]

  • 31. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
    Iwasaki T, Murakami M, Sugisaki C, Sobue S, Ohashi H, Asano H, Suzuki M, Nakamura S, Ito M, Murate T.
    Pathol Int; 2008 Jun 01; 58(6):353-60. PubMed ID: 18477214
    [Abstract] [Full Text] [Related]

  • 32. [Chromosomal structural changes in patients with myelodysplastic syndrome].
    Yu Y, Liu XP, Liu SH, Yu MH, Zhang Y, Xiao ZJ.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 16; 87(38):2693-7. PubMed ID: 18167247
    [Abstract] [Full Text] [Related]

  • 33. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
    Hidaka T, Shide K, Shimoda H, Kameda T, Toyama K, Katayose K, Kubuki Y, Nagata K, Takenaka K, Akashi K, Okamura T, Niho Y, Mizoguchi H, Omine M, Ozawa K, Harada M, Shimoda K.
    Eur J Haematol; 2009 Oct 16; 83(4):328-33. PubMed ID: 19549278
    [Abstract] [Full Text] [Related]

  • 34. [Splenectomy in programmed therapy of aplastic anemia].
    Mikhaĭlova EA, Savchenko VG, Ustinova EN, Vinogradova MA, Kokhno AV, Karagiulian SR, Danishian KI, Grzhimolovskiĭ AV, Zakharov GN.
    Ter Arkh; 2006 Oct 16; 78(8):52-7. PubMed ID: 17078218
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of DNA cytometry in combination with AgNOR investigation.
    Coric M, Ladika-Davidovic B, Bumber Z, Danic D, Vuletic LB, Seiwerth S.
    Acta Otolaryngol; 2007 Dec 16; 127(12):1332-7. PubMed ID: 17851903
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. DNA content in malignant salivary gland tumours.
    Monteiro LS, Palmeira C, Bento MJ, Lopes C.
    Oral Dis; 2009 May 16; 15(4):295-301. PubMed ID: 19320959
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.